Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3

Journal of Cell Biology

Volumn 175, Issue 1, 2006, Pages 179-191

  Saunders, W Brian ^a   Bohnsack, Brenda L ^d   Faske, Jennifer B ^a   Anthis, Nicholas J ^a   Bayless, Kayla J ^a   Hirschi, Karen K ^d   Davis, George E ^a,b,c  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c University of Missouri   (United States)

^d CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM 15; INTERSTITIAL COLLAGENASE; METALLOPROTEINASE; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CAPILLARY; CELL INVASION; CONTROLLED STUDY; DRUG INHIBITION; ENDODERM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MESENCHYME CELL; MORPHOGENESIS; MUTAGENESIS; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ADAM PROTEINS; ANGIOGENESIS INHIBITORS; ANIMALS; CAPILLARIES; CATTLE; COLLAGEN; EMBRYO; EMBRYO, MAMMALIAN; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 10; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MEMBRANE PROTEINS; MICE; MODELS, CARDIOVASCULAR; MUTAGENESIS; PERICYTES; RNA INTERFERENCE; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 33749542764     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200603176     Document Type: Article

References (43)

1. Anand-Apte, B., M.S. Pepper, E. Voest, R. Montesano, B. Olsen, G. Murphy, S.S. Apte, and B. Zetter. 1997. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest. Ophthalmol. Vis. Sci. 38:817-823.
2. Baker, A.H., D.R. Edwards, and G. Murphy. 2002. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115:3719-3727.
3. Bayless, K.J., and G.E. Davis. 2003. Sphingosine-1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices. Biochem. Biophys. Res. Commun. 312:903-913.
4. Bell, S.E., A. Mavila, R. Salazar, K.J. Bayless, S. Kanagala, S.A. Maxwell, and G.E. Davis. 2001. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J. Cell Sci. 114:2755-2773.
5. Bohnsack, B.L., L. Lai, P. Dolle, and K.K. Hirschi. 2004. Signaling hierarchy downstream of retinoic acid that independently regulates vascular remodeling and endothelial cell proliferation. Genes Dev. 18:1345-1358.
6. Brew, K., D. Dinakarpandian, and H. Nagase. 2000. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta. 1477:267-283.
7. Campbell, R.E., O. Tour, A.E. Palmer, P.A. Steinbach, G.S. Baird, D.A. Zacharias, and R.Y. Tsien. 2002. A monomeric red fluorescent protein. Proc. Natl. Acad. Sci. USA. 99:7877-7882.
8. Carmeliet, P. 2005. Angiogenesis in life, disease and medicine. Nature. 438:932-936.
9. Ceradini, D.J., A.R. Kulkarni, M.J. Callaghan, O.M. Tepper, N. Bastidas, M.E. Kleinman, J.M. Capla, R.D. Galiano, J.P. Levine, and G.C. Gurtner. 2004. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10:858-864.
10. Chun, T.H., F. Sabeh, I. Ota, H. Murphy, K.T. McDonagh, K. Holmbeck, H. Birkedal-Hansen, E.D. Allen, and S.J. Weiss. 2004. MT1-MMP- dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J. Cell Biol. 167:757-767.
11. Curry, T.E., Jr., and K.G. Osteen. 2003. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr. Rev. 24:428-465.
12. Davis, G.E., and D.R. Senger. 2005. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ. Res. 97:1093-1107.
13. Davis, G.E., and W.B. Saunders. 2006. Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. J. Invest. Dermatol. 126(Suppl.):44-56.
14. Davis, G.E., K.A. Pintar Allen, R. Salazar, and S.A. Maxwell. 2001. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J. Cell Sci. 114:917-930.
15. Davis, G.E., K.J. Bayless, and A. Mavila. 2002. Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat. Rec. 268:252-275.
16. Green, K.A., and L.R. Lund. 2005. ECM degrading proteases and tissue remodelling in the mammary gland. Bioessays. 27:894-903.
17. Hellstrom, M., M. Kalen, P. Lindahl, A. Abramsson, and C. Betsholtz. 1999. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 126:3047-3055.
18. Hellstrom, M., H. Gerhardt, M. Kalen, X. Li, U. Eriksson, H. Wolburg, and C. Betsholtz. 2001. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 153:543-553.
19. Hirschi, K.K., S.A. Rohovsky, and P.A. D'Amore. 1998. PDGF, TGF-β, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 141:805-814.
20. Horiuchi, K., G. Weskamp, L. Lum, H.P. Hammes, H. Cai, T.A. Brodie, T. Ludwig, R. Chiusaroli, R. Baron, K.T. Preissner, et al. 2003. Potential role for ADAM15 in pathological neovascularization in mice. Mol. Cell. Biol. 23:5614-5624.
21. Hotary, K., E. Allen, A. Punturieri, I. Yana, and S.J. Weiss. 2000. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 149:1309-1323.
22. Hotary, K.B., I. Yana, F. Sabeh, X.Y. Li, K. Holmbeck, H. Birkedal-Hansen, E.D. Allen, N. Hiraoka, and S.J. Weiss. 2002. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J. Exp. Med. 195:295-308.
23. Jain, R.K. 2003. Molecular regulation of vessel maturation. Nat. Med. 9:685-693.
24. Jain, R.K. 2005. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 307:58-62.
25. Kheradmand, F., and Z. Werb. 2002. Shedding light on sheddases: role in growth and development. Bioessays. 24:8-12.
26. Kryczek, I., A. Lange, P. Mottram, X. Alvarez, P. Cheng, M. Hogan, L. Moons, S. Wei, L. Zou, V. Machelon, et al. 2005. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res. 65:465-472.
27. Lafleur, M.A., P.A. Forsyth, S.J. Atkinson, G. Murphy, and D.R. Edwards. 2001. Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity. Biochem. Biophys. Res. Commun. 282:463-473.
28. Lafleur, M.A., M.M. Handsley, V. Knauper, G. Murphy, and D.R. Edwards. 2002. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J. Cell Sci. 115:3427-3438.
29. Lai, L., B.L. Bohnsack, K. Niederreither, and K.K. Hirschi. 2003. Retinoic acid regulates endothelial cell proliferation during vasculogenesis. Development. 130:6465-6474.
30. Langton, K.P., M.D. Barker, and N. McKie. 1998. Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's fundus dystrophy mutation. J. Biol. Chem. 273:16778-16781.
31. Lindahl, P., B.R. Johansson, P. Leveen, and C. Betsholtz. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 277:242-245.
32. Nagase, H., and J.F. Woessner Jr. 1999. Matrix metalloproteinases. J. Biol. Chem. 274:21491-21494.
33. Nayak, R.C., A.B. Berman, K.L. George, G.S. Eisenbarth, and G.L. King. 1988. A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. J. Exp. Med. 167:1003-1015.
34. Oh, J., R. Takahashi, S. Kondo, A. Mizoguchi, E. Adachi, R.M. Sasahara, S. Nishimura, Y. Imamura, H. Kitayama, D.B. Alexander, et al. 2001. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 107:789-800.
35. Orlidge, A., and P.A. D'Amore. 1987. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105:1455-1462.
36. Pepper, M.S. 2001. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21:1104-1117.
37. Qi, J.H., Q. Ebrahem, N. Moore, G. Murphy, L. Claesson-Welsh, M. Bond, A. Baker, and B. Anand-Apte. 2003. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 9:407-415.
38. Saunders, W.B., K.J. Bayless, and G.E. Davis. 2005. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J. Cell Sci. 118:2325-2340.
39. Seo, D.W., H. Li, L. Guedez, P.T. Wingfield, T. Diaz, R. Salloum, B.Y. Wei, and W.G. Stetler-Stevenson. 2003. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 114:171-180.
40. Spurbeck, W.W., C.Y. Ng, T.S. Strom, E.F. Vanin, and A.M. Davidoff. 2002. Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model. Blood. 100:3361-3368.
41. Stetler-Stevenson, W.G., and D.W. Seo. 2005. TIMP-2: an endogenous inhibitor of angiogenesis. Trends Mol. Med. 11:97-103.
42. von Tell, D., A. Armulik, and C. Betsholtz. 2006. Pericytes and vascular stability. Exp. Cell Res. 312:623-629.
43. Wild, A., A. Ramaswamy, P. Langer, I. Celik, V. Fendrich, B. Chaloupka, B. Simon, and D.K. Bartsch. 2003. Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors. J. Clin. Endocrinol. Metab. 88:1367-1373.